In a double-blind, randomized trial on thirty-two patients affected by classical or definite rheumatoid arthritis, we have tried the effectiveness and safety of 500 mg/day oral diftalone versus 75 mg/day oral indomethacin for a period of six to twelve months treatment. Diftalone proved to be an effective and well tolerated anti-inflammatory drug in long-term treatment of rheumatoid arthritis. Its activity and safety is at least comparable to that achieved by the use of indomethacin.
Get full access to this article
View all access options for this article.
References
1.
Corporate Medical Department of Gruppo Lepetit. Basic Information on L 5418—April 15th, 1973
2.
NicolisFBBunivaGBonolloLTenconiLTSchiavettiLPlasma levels of diftalone during treatment and their relationship with therapeutic activity in rheumatoid arthritis. International Journal of Clinical Pharmacology. (In press)
3.
NicolisFBSchiavettiLLiculF (1973) Personal communication
4.
NicolisFBSchiavettiLMarchettiMAcocellaGTherapeutic activity of diftalone in rheumatoid arthritis: a short term controlled evaluation. International Journal of Clinical Pharmacology. (In press)
